Design Therapeutics

+$0.34 (+3.07%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DSGN and other ETFs, options, and stocks.

About DSGN

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease.

CEO
Joao Siffert
Employees
38
Headquarters
Carlsbad, California
Founded
2017

DSGN Key Statistics

Market cap
635.92M
Price-Earnings ratio
—
Dividend yield
—
Average volume
163.89K
High today
$11.87
Low today
$10.96
Open price
$11.30
Volume
126.80K
52 Week high
$28.49
52 Week low
$9.61

DSGN Earnings

-$0.31
-$0.21
-$0.10
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.24 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure